Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul;39(7):2652-4.
doi: 10.1128/JCM.39.7.2652-2654.2001.

Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom

Affiliations

Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom

P A Cane et al. J Clin Microbiol. 2001 Jul.

Abstract

This work reports the variability of human immunodeficiency virus type 1 (HIV-1) protease from treated and untreated patients infected with HIV-1 subtype C in the United Kingdom. The most common primary mutation observed in treated patients was L90M. D30N, M46I, V82A/F, and I84V were seen rarely. M36I and I93L mutations were observed in nearly all samples from both treated and untreated patients and so cannot be considered as resistance-associated mutations in this subtype.

PubMed Disclaimer

References

    1. Arnold C, Barlow K L, Parry J V, Clewley J P. At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. AIDS Res Hum Retrovir. 1995;11:427–429. - PubMed
    1. Barlow K L, Tatt I D, Cane P A, Pillay D, Clewley J P. Recombinant strains of HIV type 1 in the UK. AIDS Res Hum Retrovir. 2001;17:467–474. - PubMed
    1. Boni J, Pyra H, Gebhardt M, Perrin L, Burgisser P, Matter L, Fierz W, Erb P, Piffaretti J C, Minder E, Grob P, Burckhardt J J, Zwahlen M, Schupbach J. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr. 1999;22:174–179. - PubMed
    1. Hirsh M S, Brun-Vezinet F, D'Aquila R T, Hammer S M, Johnson V A, Kuritzkes D R, Loveday C, Mellors J W, Clotet B, Conway B, Demeter L M, Vella S, Jacobsen D M, Richman D D. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA panel. JAMA. 2000;283:2417–2426. - PubMed
    1. Hu D J, Dondero T J, Rayfield M A, George J R, Schochetman G, Jaffe H W, Luo C C, Kalish M L, Weniger B G, Pau C P, Schable C A, Curran J W. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA. 1996;275:210–216. - PubMed